Cargando…
Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array
PURPOSE: To identify new polymorphisms (single nucleotide polymorphisms, SNPs) in DNA repair pathways that are associated with efficacy and toxicity in patients receiving oxaliplatin and capecitabine for advanced colorectal cancer (ACC). METHODS: We studied progression-free survival (PFS) in 91 ACC...
Autores principales: | Kweekel, D M, Antonini, N F, Nortier, J W R, Punt, C J A, Gelderblom, H, Guchelaar, H-J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720215/ https://www.ncbi.nlm.nih.gov/pubmed/19536092 http://dx.doi.org/10.1038/sj.bjc.6605134 |
Ejemplares similares
-
Regarding: ‘Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array’
por: Pander, J, et al.
Publicado: (2010) -
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group
por: Kweekel, D M, et al.
Publicado: (2008) -
UGT1A1(*)28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
por: Kweekel, D M, et al.
Publicado: (2008) -
Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance
por: Jeyapalan, J N, et al.
Publicado: (2011) -
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
por: Stoehlmacher, J, et al.
Publicado: (2004)